Skip to main content

Type 2 Diabetes in the Middle East and North Africa (MENA)

  • Chapter
  • First Online:
Diabetes Mellitus in Developing Countries and Underserved Communities

Abstract

Background: Diabetes is a growing public health problem in the MENA region with a significant impact on morbidity, mortality, and healthcare resources. Currently, the prevalence of type 2 diabetes (T2D) in the MENA region is estimated at 9.7 %.

Objective: To describe the epidemiology, principal causes, associated risk factors, cultural aspects, and challenges that contribute to the rapid rise in T2D in MENA.

Methods: Review of papers in PubMed and relevant gray literature.

Findings: The International Diabetes Federation (IDF) has identified the MENA region as having the highest prevalence of diabetes in the world. Approximately 37 million people have diabetes and this number is expected to rise dramatically. This increase may be attributed to multiple risk factors, including an increased prevalence of obesity, physical inactivity, and change in dietary patterns. In addition, there are factors unique to MENA that contribute to the diabetes epidemic. These include cultural factors and the increased prevalence of hepatitis C in few countries.

Conclusion: Prevention, early identification, and effective intervention are key components to effective T2D care in MENA. These strategies may reduce the expanding economic burden associated with T2D care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. International Diabetes Federation. IDF diabetes. 7th ed. Brussels: International Diabetes Federation; 2015. http://www.diabetesatlas.org.

  2. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.

    Article  Google Scholar 

  3. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS. Diabetes mellitus in saudi arabia. Saudi Med J. 2004;25:1603–10.

    PubMed  Google Scholar 

  4. Habeb AM, Al-Magamsi MS, Halabi S, Eid IM, Shalaby S, Bakoush O. High incidence of childhood type 1 diabetes in Al-Madinah, North West Saudi Arabia (2004–2009). Pediatr Diabetes. 2011;12(8):676–81.

    Article  PubMed  Google Scholar 

  5. Al-rubeaan K. International journal of diabetes mellitus type 2 diabetes mellitus red zone. Int J Diabetes Mellitus. 2010;2:1–2.

    Article  Google Scholar 

  6. Jain S, Saraf S. Type 2 diabetes mellitus—its global prevalence and therapeutic strategies. Diabetes Metab Syndr: Clin Res Rev. 2010;4:48–56.

    Article  Google Scholar 

  7. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.

    Article  PubMed  Google Scholar 

  8. Wang DD, Bakhotmah BA, Hu FB, Alzahrani HA. Prevalence and correlates of diabetic peripheral neuropathy in a saudi arabic population: a cross-sectional study. PLoS One. 2014;9(9):e106935.

    Article  PubMed  PubMed Central  Google Scholar 

  9. El-Asrar AMA, Al-Rubeaan KA, Al-Amro SA, Kangave D, Moharram OA. Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol. 1998;22(3):155–61.

    Article  PubMed  Google Scholar 

  10. Jbour AS, Jarrah NS, Radaideh AM, Shegem NS, Bader IM, Batieha AM, Ajlouni KM. Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan. Saudi Med J. 2003;24(7):761–4.

    PubMed  Google Scholar 

  11. El-Rufaie OE, Bener A, Ali TA, Abuzeid M. Psychiatric morbidity among type II diabetic patients: a controlled primary care survey. Prim Care Psychiatry. 1997;3:189–94.

    Google Scholar 

  12. AlQuaiz AM, Siddiqui AR, Qureshi RH, Fouda MA, AlMuneef MA, Habib FA, Turkistani IM. Women health in Saudi Arabia: a review of non-communicable diseases and their risk factors. Pak J Med Sci. 2014;30(2):422.

    Google Scholar 

  13. EL-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009. p. 431.

    Google Scholar 

  14. Population Council. http://www.popcouncil.org/uploads/pdfs/2010PGY_SYPEFinalReport_FrontMatter.pdf.

  15. Ibrahim MM, Elamragy AA, Girgis H, et al. Cut off values of waist circumference & associated cardiovascular risk in Egyptians. BMC Cardiovasc Disord. 2011;11:53.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Herman WH, Ali MA, Aubert RE, et al. Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med. 1995;12(12):1126–31.

    Article  CAS  PubMed  Google Scholar 

  17. Mirmiran P, Sherafat-Kazemzadeh R, Jalali-Farahani S, Azizi F. Childhood obesity in the Middle East: a review/Revue sur l’obésité de l’enfant au Moyen-Orient. East Mediterr Health J. 2010;16(9):1009.

    CAS  PubMed  Google Scholar 

  18. Al-Hazzaa HM, Abahussain NA, Al-Sobayel HI, Qahwaji DM, Musaiger AO. Physical activity, sedentary behaviors and dietary habits among Saudi adolescents relative to age, gender and region. Int J Behav Nutr Phys Act. 2011;8(1):140.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zadjali F, Al-Yahyaee S, Hassan MO, Albarwani S, Bayoumi RA. Association of adiponectin promoter variants with traits and clusters of metabolic syndrome in Arabs: family-based study. Gene. 2013;527(2):663–9.

    Article  CAS  PubMed  Google Scholar 

  20. Alkhateeb A, Al-Azzam S, Zyadine R, Abuarqoub D. Genetic association of adiponectin with type 2 diabetes in Jordanian Arab population. Gene. 2013;512(1):61–3.

    Article  CAS  PubMed  Google Scholar 

  21. Mtiraoui N, Ezzidi I, Turki A, Chaieb A, Mahjoub T, Almawi WY. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract. 2012;97(2):290–7.

    Article  CAS  PubMed  Google Scholar 

  22. Nemr R, Almawi AW, Echtay A, Sater MS, Daher HS, Almawi WY. Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population. Diabetes Res Clin Pract. 2012;95(2):e37–40.

    Article  CAS  PubMed  Google Scholar 

  23. Nemr R, Echtay A, Dashti EA, Almawi AW, Al-Busaidi AS, Keleshian SH, Irani-Hakime N, Almawi WY. Strong association of common variants in the IGF2BP2 gene with type 2 diabetes in Lebanese Arabs. Diabetes Res Clin Pract. 2012;96(2):225–9.

    Article  CAS  PubMed  Google Scholar 

  24. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, Al-Khadra A, Al-Mazrou YY, Al-Maatouq MA, Khan NB, Al-Marzouki K, Al-Harthi SS, Abdullah M, Al-Shahid MS. Prevalence of physical activity and inactivity among Saudis aged 30–70 years. A population-based cross-sectional study. Saudi Med J. 2007;28(4):559–68.

    PubMed  Google Scholar 

  25. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A. 2010;107:14757–62.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chehadeh W, Abdella N, Ben-Nakhi A, et al. Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection. J Gastroenterol Hepatol. 2009;24:42–8.

    Article  PubMed  Google Scholar 

  27. Chehadeh W, Kurien SS, Abdella N, et al. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. J Infect Public Health. 2011;4:200–6.

    Article  PubMed  Google Scholar 

  28. Greca LF, Pinto LC, Rados DR, et al. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection. Braz J Med Biol Res Rev Bras Pesqui Méd Biol Soc Bras Biofís … [et al]. 2012;45:284–90.

    CAS  Google Scholar 

  29. Huang JF, Yu ML, Huang CF, et al. The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy. Liver Int. 2012;32:962–9.

    Article  CAS  PubMed  Google Scholar 

  30. FAO/RNEA. Report of the workshop on implementation of the International Code of Conduct on the distribution and use of pesticides in the Near East, 16–21 Sept 1995, Cairo; 1995.

    Google Scholar 

  31. WRI. Pesticides and the immune system: the public health risks. Washington, DC: World Resources Institute; 1996.

    Google Scholar 

  32. Ambio O. Pesticide use, habits and health awareness among Egyptian farmers. Ann Occup Hyg. 1996;40(5):499–509.

    Article  Google Scholar 

  33. Wessels D, Barr DB, Mendola P. Use of biomarkers to indicate exposure of children to organophosphate pesticides: implications for a longitudinal study of children’s environmental health. Environ Health Perspect. 2003;111(16):1939–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mansour SA. Pesticide exposure—Egyptian scene. Toxicology. 2004;198(1–3):91–115.

    Article  CAS  PubMed  Google Scholar 

  35. El-Sebae AH, Zeid MA, Saleh MA. Status and environmental impact of toxaphene in the third world—a case study of African agriculture. Chemosphere. 1993;27(10):2063–72.

    Article  CAS  Google Scholar 

  36. Raafat N, Abass MA, Salem HM. Malathion exposure and insulin resistance among a group of farmers in Al-Sharkia governorate. Clin Biochem. 2012;45:1591–5.

    Article  CAS  PubMed  Google Scholar 

  37. Lee DH, Steffes MW, Sjödin A, et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6(1), e15977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Brunner EJ, Mosdøl A, Witte DR, Martikainen P, Stafford M, Shipley MJ, Marmot MG. Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. Am J Clin Nutr. 2008;87(5):1414–21.

    CAS  PubMed  Google Scholar 

  39. Hu EA, Pan A, Malik V, Sun Q. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. BMJ. 2012;344:e1454.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Fields J, Trivedi NJ, Horton E, et al. Vitamin D in the Persian Gulf: integrative physiology and socioeconomic factors. Curr Osteoporos Rep. 2011;9:243–50.

    Article  PubMed  Google Scholar 

  41. Musaiger AO. Overweight and obesity in the Arab countries: the need for action. Arab Cent Nutr. 2007;1:1–8.

    Google Scholar 

  42. Musaiger AO, Al-Ansari MS. Barriers to practicing physical activity in the Arab countries, in nutrition and physical activity in the arab countries of the near east. Musaiger AO and Meladi SS, (eds). FAO/Cairo Regional Office, Cairo, Egypt. 2000.

    Google Scholar 

  43. Khattab A, Javaid A, Iraqi G, Alzaabi A, Kheder AB, Koniski ML, Shahrour N, Taright S, Idrees M, Polatli M, Rashid N, El Hasnaoui A, BREATHE Study Group. Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106:S16–24.

    Article  PubMed  Google Scholar 

  44. Al-Maskari F, El-Sadig M, Al-Kaabi JM, Afandi B, Nagelkerke N, Yeatts KB. Knowledge, attitude and practices of diabetic patients in the United Arab Emirates. PLoS One. 2013;8(1):e52857.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Koura MR, Khairy AE, Abdel-Aal NM, et al. The role of primary health care in patient education for diabetes control. J Egypt Public Health Assoc. 2001;76(0013-2446 (Print)):241–64.

    CAS  PubMed  Google Scholar 

  46. Shams ME, Barakat EA. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J. 2010;18(4):225–32.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Al-Ahmadi H, Roland M. Quality of primary health care in Saudi Arabia: a comprehensive review. International J Qual Health Care. 2005;17(4):331.

    Article  Google Scholar 

  48. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393.

    Article  PubMed Central  Google Scholar 

  49. Hajat C, Harrison O, Al Siksek Z. Diagnostic testing for diabetes using HbA1c in the Abu Dhabi population Weqaya: the Abu Dhabi cardiovascular screening program. Diabetes Care. 2011;34(11):2400–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract. 2007;77(3):438–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasmin Khan MD, MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Khan, Y., Hamdy, O. (2017). Type 2 Diabetes in the Middle East and North Africa (MENA). In: Dagogo-Jack, S. (eds) Diabetes Mellitus in Developing Countries and Underserved Communities. Springer, Cham. https://doi.org/10.1007/978-3-319-41559-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-41559-8_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41557-4

  • Online ISBN: 978-3-319-41559-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics